- Organizations: Luminopia
Products
Luminopia's amblyopia treatment earns Anthem insurance coverage
FDA-cleared binocular digital therapy platform is indicated for pediatric patients aged 4 to 12 associated with anisometropia and/or mild strabismus.Products
FDA grants expanded clearance for Luminopia binocular amblyopia therapy
Updated label for the VR-based digital platform expands indications to include pediatric patients aged 8 to 12.Research
Real-world Luminopia data supports pediatric amblyopia improvement
Products